The Working Group on Mechanical Circulatory Support of the National Heart, Lung, and Blood Institute: Artificial Heart and Assist Devices: Directions, Needs, Costs, Societal and Ethical Issues , US Dept of Health and Human Services publication (NIH) 85-2723. Bethesda, Md, Public Health Service, 1985;.
Evans RW, Manninen DL, Gersh BJ, et al: The need for and supply of donor hearts for transplantation. J Heart Transplant 1984;;4:57-62.
Evans RW, Manninen DL, Overcast TD, et al: The National Heart Transplantation Study: Final Report . Seattle, Battelle Human Affairs Research Centers, 1984;, vols 1-5.
Akutsu T, Kolff WJ: Permanent substitute for valves and hearts. Trans Am Soc Artif Intern Organs 1958;;4:230.
Dew PA, Olsen DB, Kessler TR, et al: Mechanical failures in in vivo and in vitro studies of pneumatic total artificial hearts. Trans Am Soc Artif Intern Organs 1984;;30:112-116.
Hastings WL, Aaron JL, Deneris J, et al: A retrospective study of nine calves surviving five months on the pneumatic total artificial heart. Trans Am Soc Artif Intern Organs 1981;;27:71.
Chiang BY, Olsen DB, Dries D, et al: An analysis of animals surviving over 100 days on the total artificial heart. Artif Organs 1983;;7:12.
Jarvik R, Heimes HP, Rosenberg G, et al: Panel Conference: Portable Artificial Heart Systems. Trans Am Soc Artif Intern Organs 1983;;29:754-756.
Mochizuki T, Hastings WL, Olsen DB, et al: Postoperative hemodynamic changes in calves implanted with total artificial hearts designed for human application. Trans Am Soc Artif Intern Organs 1980;;26:55-59.
Jarvik RK, Olsen DB, Kessler TR, et al: Criteria for human total artificial heart implantation based on steady state animal data. Trans Am Soc Artif Intern Organs 1977;;23:535-541.
Murray KD, Hughes S, Bearnson D, et al: Infection in total artificial heart recipients. Trans Am Soc Artif Intern Organs 1983;;29:539-545.
Murray KD, Abbott T, DeVries WC, et al: The microscopic evaluation of skin buttons used in a long-term human total artificial heart patient. Trans Am Soc Artif Intern Organs 1986;;32:42-45.
Cooley DA, Liotta D, Hallman GL, et al: Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 1969;;24:723.
Frazier OH, Akutsu T, Cooley DA: Total artificial heart utilization in man. Trans Am Soc Artif Intern Organs 1982;;28:534-537.
Cooley DA: Staged cardiac transplantation: Report of three cases. Heart Transplantation 1982;;1(
(2)
):145.
DeVries WC, Anderson JL, Joyce LD, et al: Clinical use of the total artificial heart. N Engl J Med 1984;;310:273-278.
Joyce LD, DeVries WC, Hastings WL, et al: Response of the human body to the first permanent implant of the Jarvik-7 total artificial heart. Trans Am Soc Artif Intern Organs 1983;;29:81-87.
Anderson FL, DeVries WC, Anderson JL, et al: Evaluation of total artificial heart performance in man. Am J Cardiol 1984;;54:394-398.
DeVries WC, Joyce LD: The artificial heart. Ciba Clin Symp 1983;;35:1-32.
Mays JB, Williams MA, Barker LE, et al: Clinical management of total artificial heart drive systems. JAMA 1988;;259:881-885.
Starling EH: The Linacre Lecture on the Law of the Heart, Cambridge, 1915 . London, Longmans Green & Co, 1918;.
Olsen DB, Kolff WJ, Lawson J, et al: Saving the aortic and pulmonary valves with total heart replacement. Trans Am Soc Artif Intern Organs 1976;;22:468-476.
Hastings WL, Joyce LD, DeVries WC, et al: Drive system management in the clinical implantation of the Jarvik-7 total artificial heart. Prog Artif Organs 1983;, pp 219-220.
Willshaw P, Nielsen SD, Nanas J, et al: A cardiac output monitor and diagnostic unit for pneumatically driven artificial hearts. Artif Organs 1984;;8:215-219.
Mays JB, Williams MA, Barker LE, et al: Diagnostic monitoring and drive system management of patients with total artificial heart. Heart Lung 1986;;15:466-475.
DeVries WC, Mays JB, Hastings WL, et al: Effect of drive system modification on hematologic profiles of two permanent total artificial heart recipients. Abstracts Am Soc Artif Intern Organs 1986;;15:15.
Levinson MM, Copeland JG, Smith RG, et al: Indexes of hemolysis in human recipients of the Jarvik-7 total artificial heart: A cooperative report of 15 patients. J Heart Transplant 1986;;3:236-248.
Dobbins JJ, Johnson GS, Kunin CM, et al: Postmortem microbiological findings of two total artificial heart recipients. JAMA 1988;;259:865-869.
Schwab TR, Edwards BS, DeVries WC, et al: Atrial endocrine function in humans with the artificial heart. N Engl J Med 1986;;315:1398-1401.
Joyce LD, Johnson KE, Pierce WS, et al: Summary of the world experience with clinical use of total artificial heart and cardiac support devices. J Heart Transplant 1986;;3:229-235.
DeVries WC: Surgical technique for implantation of the Jarvik-7-100 total artificial heart. JAMA 1988;;259:875-880.
Duncan PE, Hughes SD, Jarvik RK, et al: Choice of the Medtronic-Hall valve in the Jarvik-7 total artificial heart. Abstracts Am Soc Artif Intern Organs 1984;;13:3.
Harker LA: Concepts of thrombus formation, dissolution, and antithrombotic therapy , in Guidelines for Blood-Material Interaction . US Dept of Health and Human Services publication (NIH) 85-2185, 1985;, pp 19-63.
Salzman EW, Merrill EW: Interaction of blood with artificial surfaces , in Colman RW Hirsh J, Marder VJ, et al (eds): Hemostasis and Thrombosis . Philadelphia, JB Lippincott, 1987;, pp 1335-1347.
Mason RG, Mohammad SF, Chuang HYK: Artificial devices in clinical practice , in Colman RW, Hirsh J, Marder VJ, et al (eds): Hemostasis and Thrombosis . Philadelphia, JB Lippincott, 1987;, pp 1348-1365.
Harker LA, Schlicter SJ: Studies of platelet and fibrinogen kinetics in patient with prosthetic heart valves. N Engl J Med 1970;;283:1302-1305.
Sullivan JM, Harken DE, Gorlin R: Pharmacologic control of thromboembolic complications of cardiac valve replacement. N Engl J Med 1971;; 284:1391-1394.
Hanson SR, Harker LA, Bjornsson TD: Effects of platelet-modifying drugs on arterial thromboembolism in baboons. J Clin Invest 1985;;75:1591-1599.
Harker LA, Malpass TW, Branson HE, et al: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980;;56:824-834.
Craddock PR, Fehr J, Dalmasso AP, et al: Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977;;59:879-888.
Chenoweth DE, Cheung AK, Henderson LW: Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int 1983;;24:764-769.
Hammerschmidt DE, Stoncek DF, Bowers TK, et al: Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981;;81:370-377.
Chenoweth DE, Cooper SW, Hugh TE, et al: Complement activation during cardiopulmonary bypass. N Engl J Med 1981;;304:497-503.
Wellhausen SR, Ward RA, Johnson GS, et al: Immunologic complications of long-term implantation of a total artificial heart. J Clin Immunol , in press.
Ward RA, Wellhausen SR, Dobbins JJ, et al: Thromboembolic and infectious complications of total artificial heart implantation. Ann NY Acad Sci , in press.
Stelzer GT, Ward RA, Wellhausen SR, et al: Alterations in select immunologic parameters following total artificial heart implantation. Artif Organs , in press.
Kunin CM, Dobbins JJ, Melo JC, et al: Infectious complications in four long-term recipients of the Jarvik-7 artificial heart. JAMA 1988;;259:860-864.
Gristina AG, Dobbins JJ, Giammara B, et al: Biomaterial-centered sepsis and the total artificial heart: Microbial adhesion vs tissue integration. JAMA 1988;;259:870-874.